Valeant

$1,000, 5 Years Later: Valeant's Wild Ride To Bausch Health

Bausch Sees Clearer With Less Debt

Valeant's CEO Details The Company's 'Great Progress' And What's Next

Bausch Sees Clearer With Less Debt

Valeant's CEO Details The Company's 'Great Progress' And What's Next

Valeant Investors: Cantor Says It's Time To Stop Waiting For The Other Shoe To Drop

Valeant's $930 Million iNova Pharma Sale Boosts Stock Price

Valeant Investors: Cantor Says It's Time To Stop Waiting For The Other Shoe To Drop

Valeant's $930 Million iNova Pharma Sale Boosts Stock Price

Valeant Soars 14% After Encouraging Q1, Raised Guidance

Valeant's SILIQ Will Be Priced At $3,500 A Month

Valeant Recent News

Bill Ackman Is Killin' It In Chipotle

Gadfly's Nisen: Valeant's 'Financial Wizardry' Doesn't Change The Long-Term Outlook

Valeant's Post-Ackman Recovery Is Characterized By 'Less Money, More Problems'

Valeant: Traders Vs. Portfolio Managers

Pershing Square Defends Valeant's Progress, Can't Defend Its Stock Performance

Valeant's Asset Sale To L'Oreal Explained

Valeant's Laundry List: Products, Divestitures And Debt Load

Valeant Shares Carry Too Much Risk To Be Recommended As An Investment: Wells Fargo

Bill Ackman's Pershing Square Releases Q3 Letter To Shareholders

Criminal Charges Against Former Valeant Exec 'Not Pertinent But Underscores Cautious Outlook'

Is Allergan Going After Valeant's Eye Surgery Assets?

Analysts Having Difficulty Getting Comfortable With Valeant's Fundamentals

What Did Valeant Look Like Last Time The Stock Was Under $15?

A Deeper Look Into Valeant's Assets As It Searches For Salix Buyer

Valeant's Salix Story: To Sell Or Not To Sell?

Ackman: Valeant Doesn't Have To Sell Core Assets

Valeant Management On Q1 Call: 'We Don't Feel We Can Accurately Predict' GAAP Earnings

Can Broadcom Or Medtronic Offer Up An Earnings Surprise?

Report: Valeant Rejected A Takeover Offer Prior To Hiring Papa As CEO

Piper Jaffray Analyst: Latest Report On Valeant 'Doesn't Surprise Me'

Valeant's Price Cut To Hospitals Just Lip Service?

Ackman: Valeant Made Some Mistakes, But It's Not A Sewer

Senator Calls Out Bill Ackman, Questions His Senate Hearing Comments On Drug Pricing